Immucell (ICCC) Treasury Shares (2010 - 2026)
Immucell's (ICCC) quarterly Treasury Shares came in at $130760.0 in Q4 2025, down 5.58% YoY from $138482.0 in Q4 2024, and little changed on a QoQ basis from $130760.0 in Q3 2025.
Immucell (ICCC) Treasury Shares (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Treasury Shares data on file, last reported at $130760.0 in Q4 2025.
- Quarterly Treasury Shares fell 5.58% year-over-year to $130760.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $130760.0 (down 5.58% YoY) and the FY2025 annual result came in at $130760.0, down 5.58% from the prior year.
- Treasury Shares steadied at $130760.0 in Q4 2025, from $130760.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $349000.0 in Q2 2025 to a low of $59771.0 in Q3 2025.
- A 5-year average of $91911.5 and a median of $67301.0 in 2022 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2021 — Treasury Shares retreated 16.02% — and 2023, when it gained 0.0%.
- Tracing ICCC's Treasury Shares over 5 years: stood at $158171.0 in 2021, then retreated by 6.92% to $147233.0 in 2022, then dropped by 5.94% to $138482.0 in 2023, then changed by 0.0% to $138482.0 in 2024, then decreased by 5.58% to $130760.0 in 2025.
- The last three Treasury Shares figures came in at $130760.0 (Q4 2025), $130760.0 (Q3 2025), and $130760.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Immucell | 91.19 Mn | 82.33 Mn | 2.44 Mn | 23,425.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23,425.00 |
| Jun 30, 2026 | 77,342.00 |
| Jun 30, 2026 | 23,425.00 |
| Jun 30, 2026 | 77,342.00 |
| Dec 31, 2025 | 59,771.00 |
| Dec 31, 2025 | 59,771.00 |
| Dec 31, 2025 | 130,760.00 |
| Dec 31, 2025 | 130,760.00 |
| Sep 30, 2025 | 130,760.00 |
| Sep 30, 2025 | 130,760.00 |
| Sep 30, 2025 | 59,771.00 |
| Sep 30, 2025 | 59,771.00 |
| Jun 30, 2025 | 349,000.00 |
| Jun 30, 2025 | 130,760.00 |
| Jun 30, 2025 | 130,760.00 |
| Jun 30, 2025 | 349,000.00 |
| Mar 31, 2025 | 138,482.00 |
| Mar 31, 2025 | 283,000.00 |
| Mar 31, 2025 | 283,000.00 |
| Mar 31, 2025 | 138,482.00 |